Willow Curve Clinical Trials
Yes, the Willow Curve has been tested in double-blind studies. And, yes, it has been proven effective. Although we continue to test our science to increase its effectiveness, various studies have been conducted over the years to prove (and improve) the effectiveness of the Willow Curve.
Summary of Latest Clinical Trial
Published in 2013, four doctors from the University of Toledo College of Medicine in Toledo, Ohio, conducted a double-blind study to measure the effectiveness of the Willow Curve (formerly the WilloMD). The details of the study may be found attached hereto, along with the below-referenced journal abstract. To quote the publication: “Overall, the device statistically outperformed the sham form (p=0.04) with regard to the degree of angle flexion tolerated before pain perception, with the fully-active device (thermal kinetic only) borderline outperforming the sham device. The most consistently improved outcomes occurred with the use of the fully-activated device compared with the partially-activated devices, suggesting that there may be some synergistic benefit arising from the combined modalities (ie, thermal kinetic plus photonic energies).”
Clinical Evaluation of a Noninvasive Technology for the Treatment of Chronic Joint Symptoms
(Bachmann, Chelucci, et al, 2013, Orthopedic Research and Reviews).
Abstract: A device that emits thermal kinetic energy and photonic energy has been developed for the treatment of chronic knee pain. We conducted a clinical trial pilot study in which 69 patients with chronic knee pain were randomly allocated to one of four treatment groups with approximately 17 patients per group. One group was treated with the operational device; a second group was treated with the device emitting only thermal kinetic energy; a third group was treated with the device configured to emit only photonic energy; and the fourth group was treated with a complete sham device. Several parameters (e.g., number of steps climbed, knee circumferences, pain rank during flexion, and flexion angle achieved prior to pain perception) were assessed immediately prior to treatment and immediately after the application of a 25-minute treatment under fully blinded conditions. Analysis of variance with the Tukey multiple comparisons procedure was used for comparing treatment results. The fully or partially activated device was superior to the sham device in patients with chronic knee pain. The results suggest that this device may have benefit for patients with chronic knee pain, and that larger, more robust studies of the device are warranted.